The role of PET imaging in lymphoma

被引:64
作者
Burton, C
Ell, P
Linch, D
机构
[1] UCL, Dept Haematol, London WC1E 8HX, England
[2] Middlesex Hosp, Dept Nucl Med, London, England
关键词
2-fluoro-2-deoxy-D-glucose-positron emission tomography; positron emission tomography; lymphoma; non-Hodgkin's lymphoma; hodgkin lymphoma/disease;
D O I
10.1111/j.1365-2141.2004.05069.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Positron emission tomography using fluorine-18 (FDG-PET) is increasingly used in the staging and follow-up of malignant lymphomas, although its precise role has not yet been determined. This review considers the results reported at-the different stages in the disease history and separately considers the major histological subtypes. Attention is given to the situations in which PET scanning is most likely to influence management. Finally, this review discusses ongoing developments in PET scanning with improved resolution and different radiolabelled tracers.
引用
收藏
页码:772 / 784
页数:13
相关论文
共 84 条
[31]  
Hustinx R, 2003, J NUCL MED, V44, P533
[32]  
ISRAEL O, 1988, CANCER, V61, P2439, DOI 10.1002/1097-0142(19880615)61:12<2439::AID-CNCR2820611208>3.0.CO
[33]  
2-Q
[34]  
Jaffe ES., 2001, PATHOLOGY GENETICS T
[35]  
Jager PL, 1999, EUR J NUCL MED, V26, P972
[36]  
Jager PL, 2001, J NUCL MED, V42, P432
[37]   Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging [J].
Jerusalem, G ;
Beguin, Y ;
Fassotte, MF ;
Najjar, F ;
Paulus, P ;
Rigo, P ;
Fillet, G .
BLOOD, 1999, 94 (02) :429-433
[38]   Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease [J].
Jerusalem, G ;
Beguin, Y ;
Fassotte, MF ;
Belhocine, T ;
Hustinx, R ;
Rigo, P ;
Fillet, G .
ANNALS OF ONCOLOGY, 2003, 14 (01) :123-130
[39]  
Jerusalem G, 2000, HAEMATOLOGICA, V85, P613
[40]   Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL) [J].
Jerusalem, G ;
Beguin, Y ;
Najjar, F ;
Hustinx, R ;
Fassotte, MF ;
Rigo, P ;
Fillet, G .
ANNALS OF ONCOLOGY, 2001, 12 (06) :825-830